Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Chemotherapy

NICE recommends topotecan for cervical cancer

Cancer drug topotecan will now be available on the NHS for the treatment of advanced or recurring cervical cancer.

Scientists identify genetic markers for common side-effect of taxane chemotherapy

US scientists have identified genetic markers associated with a common side-effect of taxane-based chemotherapy called peripheral neuropathy.

Faster chemo technique increases survival in children with neuroblastoma

Chemotherapy given with shorter intervals between treatments than conventional chemotherapy increases survival rates by two thirds in children with high-risk neuroblastoma...

New research sheds light on ways to improve treatment for aggressive breast cancer

Changing the order that chemotherapy drugs are given to breast cancer patients before surgery makes treatment much more effective, according to trial results presented at...

New research moves us one step closer to personalised breast cancer treatment

CANCER RESEARCH UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who wonїt benefit from commonly used...

NICE approves new prostate cancer treatment

The UK medical watchdog NICE has approved the use of chemotherapy drug docetaxel to treat men with advanced prostate cancer.

Lower doses enable older bowel cancer patients to take part in chemotherapy trials

Older patients with bowel cancer may be able to take part in clinical trials if the doses of experimental chemotherapy drugs are lowered.

BRCA1 gene points way to targeting breast cancer treatment

Testing tumours for the breast cancer gene BRCA1 could be a powerful way of predicting how patients will respond to chemotherapy, scientists from Breast Cancer Campaign...

Trial results raise hope of more effective pancreatic cancer treatment

A major international trial has shown a commonly used chemotherapy drug is as effective at helping prevent pancreatic cancer returning after surgery as the more expensive...

Scientists shed new light on why pancreatic cancer drugs can fail

Cancer Research UK scientists led an international team of investigators who have discovered a new mechanism that may explain why pancreatic cancer patients are often...

Pages